Remodulin (Treprostinil)

Remodulin (treprostinil) is a prostacyclin mimetic used for the treatment of adults with pulmonary arterial hypertension (PAH; WHO Group 1), which is high blood pressure in the arteries of the lungs. This therapeutic drug can reduce symptoms associated with exercise. Remodulin was studied primarily in those with NYHA Functional Class II-IV symptoms. It is unknown if this medicine is safe and promising in children. In people with pulmonary arterial hypertension (PAH) who need to switch from epoprostenol, Remodulin is approved to slow the worsening of symptoms.

Recommended Dosage: The recommended initial dosage of Treprostinil for patients new to prostacyclin infusion therapy is 1.25 ng/kg/min. Dosage can be increased based on clinical response (increments of 1.25 ng/kg/min per week for the initial four weeks of treatment, later 2.5 ng/kg/min per week). Abrupt cessation must be avoided.

• The use of an intravenous (IV) catheter to deliver Remodulin can increase the risk of critical bloodstream infections. Closely look catheter site for any swelling, redness, or signs of infection. Follow good hygiene practices to keep the area clean and prevent any potential complications.
• Abruptly halting or significantly reducing the doses of Remodulin may worsen pulmonary arterial hypertension (PAH). Adjust doses under medical supervision to prevent serious complications or a potentially life-threatening increase in PAH symptoms.
• Higher drug exposure may occur in patients with liver impairments which may increase the risk of side effects. Start therapy with a reduced dose, precisely monitor for side effects, and adjust the dose on behalf of individual tolerability and liver function.
• Treatment with Remodulin can scale down blood pressure significantly which may potentially cause dizziness or fainting. Those with reduced baseline blood pressure or those taking other blood pressure-lowering medications should be carefully monitored to manage symptomatic hypotension.
  This therapeutic drug may increase the risk of bleeding, especially in those taking anticoagulants or with bleeding disorders. Monitor such patients for prolonged bleeding, unusual bruising, or signs of internal bleeding, and adjust therapy as required to manage the risk.
  The safety of this medicinal product in pregnancy is not established. Use it only if the potential benefit outweighs the risks

What documents are required to import REMODULIN to India?

REMODULIN (treprostinil) Injection can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order be confirmed?

The order will be confirmed only after the receipt of:
A valid prescription from the Doctor
Import permit if applicable

Is REMODULIN available in India?

REMODULIN (treprostinil injection) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability of Remodulin in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
• Medicine Price.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

REMODULIN can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of REMODULIN (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Remodulin injection price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source REMODULIN (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient's address only from New Delhi, India.

What is the Generic Name for the trade name drug Remodulin®?

Treprostinil is a Generic Name for the trade name drug Remodulin®.

What is the Manufacturer's Name of Remodulin®?

Remodulin® is manufactured by United Therapeutics Corporation.

Is Remodulin® approved by the FDA?

Yes, Remodulin® is approved by the FDA. Date of first approval: May 21, 2002.

What is the dosage and form of Remodulin® supplied?

Remodulin is supplied in 20-mL vials containing 2 mg (0.1 mg/mL), 4 mg (0.2 mg/mL), 8 mg (0.4 mg/mL), 20 mg (1 mg/mL), 50 mg (2.5 mg/mL), 100 mg (5 mg/mL), 200 mg (10 mg/mL), or 400 mg (20 mg/mL) of treprostinil for subcutaneous (SC) or intravenous (IV) use.

What are the most common side effects of Remodulin®?

The most common side effects of Remodulin® are infusion site pain and reaction, headache, nausea, jaw pain, diarrhea, edema, vasodilatation, and hypotension.

How much does Remodulin® injection cost in India?

Prices of Remodulin may fluctuate over time due to market dynamics and regulatory changes. To get the most up-to-date details on Remodulin injection cost in India, please Call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

Can Remodulin® be available in SAARC countries?

Apart from Gulf countries, Remodulin® can be available in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Remodulin® injections in these countries. We help ensure legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Remodulin® injections online in India?

Yes, one can buy Remodulin online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can facilitate the supply of Remodulin® injections through legal channels.

What are the storage conditions of Remodulin® injections?

Store this therapeutic drug at 25°C (77°F), with excursions permitted to 2 to 30°C (36 to 86°F).